| Sherri L Hoyman, DO | |
|
555 Redbird Cir, De Pere, WI 54115-7977 | |
| (920) 338-6820 | |
| Not Available |
| Full Name | Sherri L Hoyman |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 555 Redbird Cir, De Pere, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629052469 | NPI | - | NPPES |
| 36777 | Other | WV | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 36777 (Wisconsin) | Primary |
| Entity Name | Bellin Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609838473 PECOS PAC ID: 8820900749 Enrollment ID: O20031121000089 |
News Archive
The New York Times reports that while the Senate health bill "includes nearly every big idea that health economists and medical researchers have for slowing cost growth — as well as for improving the patchwork quality of American health care, ... many of the ideas, like the rule on Medicare reimbursement, have been at least partly neutered. A provision to punish hospitals for infecting their patients, for example, would cut payments for the related treatments by a mere 1 percent.
The London-based LouLou Foundation and the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania have established a Program of Excellence to develop effective treatments for children with CDKL5, a rare X-chromosome-linked genetic disorder that causes severe neuro-developmental impairment and early-onset, difficult-to-control seizures.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the emergence of new agents that have the potential to affect disease progression, the Alzheimer's disease drug market will more than triple, from $4.3 billion in 2009 to $13.3 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons shows that a drug given to some pregnant women to prevent severe respiratory ailments in preterm newborns reduces healthcare costs.
Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherri L Hoyman, DO 555 Redbird Cir, De Pere, WI 54115-7977 Ph: (920) 338-6820 | Sherri L Hoyman, DO 555 Redbird Cir, De Pere, WI 54115-7977 Ph: (920) 338-6820 |
News Archive
The New York Times reports that while the Senate health bill "includes nearly every big idea that health economists and medical researchers have for slowing cost growth — as well as for improving the patchwork quality of American health care, ... many of the ideas, like the rule on Medicare reimbursement, have been at least partly neutered. A provision to punish hospitals for infecting their patients, for example, would cut payments for the related treatments by a mere 1 percent.
The London-based LouLou Foundation and the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania have established a Program of Excellence to develop effective treatments for children with CDKL5, a rare X-chromosome-linked genetic disorder that causes severe neuro-developmental impairment and early-onset, difficult-to-control seizures.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the emergence of new agents that have the potential to affect disease progression, the Alzheimer's disease drug market will more than triple, from $4.3 billion in 2009 to $13.3 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons shows that a drug given to some pregnant women to prevent severe respiratory ailments in preterm newborns reduces healthcare costs.
Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.
› Verified 6 days ago
Dr. Rose M Cipres-jaucian, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1723 Spring Hills Ln, De Pere, WI 54115 Phone: 920-403-7982 | |
Dr. Laura Jean Gallistel, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 555 Redbird Cir Ste 200, De Pere, WI 54115 Phone: 920-338-6820 | |
Yoloxochitl Diaz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1881 Chicago St, De Pere, WI 54115 Phone: 920-403-8000 | |
Dr. Douglas Randal Zabrowski, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 555 Redbird Cir, De Pere, WI 54115 Phone: 920-969-5353 Fax: 414-337-7201 | |
Matthew R. Theado, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 555 Redbird Cir, Suite 200, De Pere, WI 54115 Phone: 920-338-6820 Fax: 920-338-6829 | |
Dr. Caitlin Quinn Barr, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 555 Redbird Cir, De Pere, WI 54115 Phone: 920-338-6820 Fax: 920-338-6829 | |
Rachael Marie Ellis, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 555 Redbird Cir, De Pere, WI 54115 Phone: 920-338-6820 Fax: 920-338-6829 |